Next Article in Journal
The Modulation of Phase II Drug-Metabolizing Enzymes in Proliferating and Differentiated CaCo-2 Cells by Hop-Derived Prenylflavonoids
Next Article in Special Issue
Dietary Oat Bran Reduces Systemic Inflammation in Mice Subjected to Pelvic Irradiation
Previous Article in Journal
To Wean or Not to Wean: The Role of Autologous Reconstructive Surgery in the Natural History of Pediatric Short Bowel Syndrome on Behalf of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP)
Previous Article in Special Issue
Perceptions of Oncology Providers and Cancer Survivors on the Role of Nutrition in Cancer Care and Their Views on the “NutriCare” Program
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Diet Quality Is Associated with Cardiometabolic Outcomes in Survivors of Childhood Leukemia

1
Research Centre, Sainte-Justine University Health Center, Department of Nutrition, Université de Montréal, Montreal, QC H3T 1C5, Canada
2
Institute of Nutrition and Functional Foods, Laval University, Quebec City, QC G1V 0A6, Canada
3
Cancer Prevention and Control Program, University of South Carolina, Columbia, SC 29208, USA
4
Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA
5
Research Centre, Sainte-Justine University Health Center, Department of Pediatrics, Université de Montréal, Montreal, QC H3T 1C5, Canada
*
Author to whom correspondence should be addressed.
Submission received: 23 June 2020 / Revised: 14 July 2020 / Accepted: 15 July 2020 / Published: 18 July 2020
(This article belongs to the Special Issue Nutrition for Cancer Survivors)

Abstract

:
There is little information about how diet influences the health of childhood acute lymphoblastic leukemia (cALL) survivors. This study explores the associations between diet quality indices, cardiometabolic health indicators and inflammatory biomarkers among cALL survivors. Participants were part of the PETALE study (n = 241, median age: 21.7 years). Adherence to 6 dietary scores and caloric intake from ultra-processed foods were calculated. Multivariate logistirac regressions, Student t-tests and Mann-Whitney tests were performed. We found that 88% of adults and 46% of children adhered poorly to the Mediterranean diet, 36.9% had poor adherence to the World Health Organisation (WHO) recommendations and 76.3% had a diet to be improved according to the HEI-2015 score. On average, ultra-processed foods accounted for 51% of total energy intake. Low HDL-C was associated with a more inflammatory diet (E-DIITM score) and higher intake of ultra-processed foods. A greater E-DII score was associated with elevated insulin resistance (HOMA-IR), and consumption of ultra-processed foods was correlated with high triglycerides. Circulating levels of TNF-α, adiponectin and IL-6 were influenced by diet quality indices, while CRP and leptin were not. In conclusion, survivors of cALL have poor adherence to dietary recommendations, adversely affecting their cardiometabolic health.

1. Introduction

Pediatric cancers are the leading causes of disease-related mortality in Canadian children [1,2] and acute lymphoblastic leukemia (ALL) is the most common of these cancers [3]. An average of 880 Canadian children under the age of 15 are diagnosed with cancer each year and the incidence of pediatric cancers has remained relatively stable since 1992 [2]. Leukemia accounts for 32% of all pediatric cancers [2]. In recent years, therapeutics advances have achieved a survival rate for childhood ALL (cALL) that exceeds 90% [4]. Therefore, the population of survivors is growing in Canada and other parts of the world [2,5,6]. Unfortunately, cALL survivors are at greater risk of developing long-term chronic health complications [7]. For example, they are seven times more likely than their siblings to develop cardiac complications such as heart failure and myocardial infarction [8]. The PETALE study (Prévenir les effets tardifs des traitements de la leucémie lymphoblastique chez l’enfant), carried out in Sainte-Justine University Health Center (SJUHC) in Montreal, PQ, Canada showed that more than 60% of children and young adult survivors of cALL exhibited at least one cardiometabolic risk factor, including dyslipidemia, pre-hypertension or hypertension, obesity and insulin resistance [9]. Compared to participants of the same age in the general population, they were at higher risk of developing the metabolic syndrome [9]. Studies in other populations of cALL survivors displayed similar findings [10,11].
Several mechanisms have been proposed to explain the cardiometabolic side effects on cALL survivors [11]. Side effects of radiotherapy [12,13] and chemotherapy [14,15], gut microbiota modifications [16,17,18], poor eating habits [19,20] and physical inactivity [21,22] have all been pinpointed in this group. In the general population, it has been established that a healthy diet influences cardiometabolic risk [23,24] while poor adherence to dietary recommendations is negatively associated with cardiometabolic health outcomes [25,26]. To assess such associations, different validated food quality indices have been used [25,27,28,29]. In particular, food quality indices or nutritional scores are tools that provide an overall rating, on a numeric scale, indicating adherence level to nutrition recommendations or overall quality of diet [30,31].
Given the major health issues that face cALL survivors, it would be prudent for them to adopt healthy eating habits. However, some studies have reported their poor adherence to dietary guidelines [32,33,34]. Apparently, survivors do not eat enough fruits and vegetables [33,35,36], dairy products [35,36], whole grains [36,37], calcium and vitamin D [37] and they consume too much sodium, meat and processed foods [33]. Nonetheless, there is little information about how their eating habits may influence their cardiometabolic status.
Here, we studied diet quality of 241 cALL survivors of the PETALE cohort using nutritional scores including five using a priori dietary patterns (MEDAS, KIDMED, HDI-2018, HEI-2015, E-DII) and two a posteriori patterns (FRAP score and contribution of ultra-processed foods to total energy intake based on the NOVA classification). We also studied the associations between diet quality indices and participants’ cardiometabolic outcomes, as well as metabolic and inflammatory profile.

2. Materials and Methods

2.1. Study Population

Participants were recruited between January 2013 and December 2016 as part of the PETALE study at SJUHC in Montreal. A detailed presentation of the PETALE study and cohort is provided in Marcoux et al. [38]. The PETALE study was designed to characterize early-onset late adverse effects namely cardiometabolic complications, cardiotoxicity, neurocognitive problems, bone morbidity and quality of life in children, adolescents and young adults who had survived cALL [38]. Participants (n = 246) were of European-descent living in the Province of Quebec and were treated for ALL at SJUHC according to Dana-Farber Cancer Institution-ALL protocols 87-01 to 2005-01. Event-free patients who had not suffered from refractory ALL, relapsed or received hematopoietic stem cell transplant 5 years or more after diagnosis were eligible. Information on participants’ treatment protocols is provided in Levy et al. [9]. The Institutional Review Board of SJHUC approved the study (approval number 2013-479) and investigations were carried out in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from study participants and/or parents/guardians.

2.2. Anthropometric, Clinical and Biochemical Assessment

Anthropometric, clinical and biochemical assessments were achieved, as previously described [9]. Waist-to-height ratio [WHtR, waist circumference (WC) (cm)/height (cm)] and body mass index [BMI, weight (kg)/height (m)2] were calculated [38]. Hypertension and pre-hypertension were determined according to current recommendations in adults and children [9]. Fasting insulin (pmol/L), glucose (mmol/L), total cholesterol (TC, mmol/L), triglycerides (mmol/L), low-density lipoprotein-cholesterol (LDL-C, mmol/L), high-density lipoprotein-cholesterol (HDL-C, mmol/L), apolipoproteins A-1 (Apo A-1, mg/mL) and B-100 (Apo B-100, g/L) and low-grade and visceral inflammation [C-reactive protein (CRP, μg/mL), tumor necrosis factor (TNF, pg/mL)-α, interleukin (IL, pg/mL)-6, adiponectin (ng/mL) and leptin (ng/mL)] were measured on fasting blood, as described previously [9,38]. The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated [39]. Cardiometabolic complications were defined and categorized [9]—obesity (yes or no), pre-hypertension/hypertension (yes or no), insulin resistance (yes or no) and dyslipidemia (yes or no). Participants with ≥2 cardiometabolic complications were identified. Cut-off values and definitions used to determine cardiometabolic outcomes in children (<18 years old) and adults are described in Supplementary Table S1 and were assessed as reported in former investigations [40,41,42].

2.3. Data Collection and Analysis for Dietary Intake

Participants’ dietary intake was recorded using a validated food frequency questionnaire consisting of 190 items. Data collection method, nutrient calculation and further classification in food groups and subgroups have been previously described [43]. For 191 participants, 3-day food records also were available and were analyzed with the Nutrific® software developed by the Department of Food Science and Nutrition, Université Laval. Nutrient values from the Nutrific application were extracted from the 2010 Canadian Nutrient File.

2.4. Assessment of Diet Quality

Data collected with the food frequency questionnaires were used to calculate the dietary scores—Mediterranean Diet Adherence Screener (MEDAS), Mediterranean Diet Quality Index for children and adolescents (KIDMED), Healthy Diet Indicator (HDI-2018), Healthy Eating Index (HEI-2015), Energy-adjusted Dietary Inflammatory Index (E-DIITM) and Ferric reducing ability of plasma (FRAP). 3-day foods records were used for the NOVA Classification.

2.4.1. Mediterranean Diet Adherence

For adults, adherence to the Mediterranean diet (MD) was determined by the 14-point MEDAS score. This score consists of 12 questions on food frequency and 2 questions on MD dietary habits—consumption of olive oil for cooking and >60 mL/day, vegetables (>4 portions/day), fruits (3/day), red meat (<1 portion/day), butter, margarine or cream (≤15 mL/day), sugary drinks (<355 mL/day), wine (≥3 glasses/week), legumes (≥3 portions/week), fish or seafood (≥3 portions/week), baked goods (<2/weeks), nuts (≥3 portions/week), preferring chicken/turkey instead of red meat and consuming boiled vegetables, pasta, rice or other dishes with a sauce of tomato, garlic or onions sautéed in olive oil. The questions are scored as either 0 or 1, reaching a maximum score of 14. Adherence is categorized as follows—≥10, strong adherence; 6–9, moderate adherence; ≤5, low adherence [44]. For children, MD adherence was assessed using an updated version of the KIDMED Index [45,46]. This index is based on 16 yes or no questions, with a total score ranging from—4 to 12. Scoring of +1 is attributed in accordance to the MD, while questions that do not reflect this type of diet are scored −1. Diet is classified in three levels—≥8, optimal MD; 4–7, improvement needed; ≤3, very low diet quality [45].

2.4.2. Healthy Diet Indicator

The HDI is based on the 2003 World Health Organization (WHO) guidelines for prevention of chronic diseases [47]. The HDI-2018 was further developed according to the updated version of the WHO Fact Sheet 2018 [48]. It includes 9 components—≥400 g of fruits and vegetables per day, <30% of fat from total energy, <10% of saturated fat from total energy, 6–11% of polyunsaturated fatty acids from total energy, <10% of free sugars from total energy, ≥25 g of dietary fiber per day, ≥3500 mg of potassium per day, <2 g of sodium and <1% of trans fat from total energy. A value of +1 is assigned when intake is within the recommended range, otherwise the score is 0. The sum of the 9 components generates a score from 0 to 9. The level of adherence is determined as follows—≥7, strong adherence; 4–6, modest adherence; and ≤3, low adherence [49].

2.4.3. Healthy Eating Index

The HEI-2015 assesses adherence to the Dietary Guidelines for Americans [50,51]. This score takes into account 14 dietary components expressed in 1000 kcal (total fruits, whole fruits, total vegetables, greens and beans, whole grains, dairy, total protein foods, seafood and plant proteins, refined grains, added sugars, fatty acids, sodium and saturated fats). Briefly, each healthy food component accounts for 5 or 10 points and unhealthy components for 0 point (i.e., refined grains ≥4.3 oz eq/1000 kcal; added sugar ≥26% of total energy; sodium ≥2 g/1000 kcal; saturated fatty acids—≥16% of total energy). The sum of the components leads to a score ranging from 0 to 100 [51,52]. A HEI-2015 score >80 indicates a good quality diet, a score ranging from 51–80 indicates a diet that needs improvement and a score <51 reflects poor quality diet [53].

2.4.4. Energy-Adjusted-Dietary Inflammatory Index

The Dietary Inflammatory Index (DII®) was developed to assess the inflammatory potential of the diet. The development and validation of the DII has been published [54,55]. Briefly, it reflects the relationship between 45 food parameters and six inflammatory biomarkers reported by 1943 research articles published through 2010. Food and nutrient consumption was first adjusted for total energy per 1000 calories. To avoid the arbitrary use of raw intake amounts, the energy-adjusted dietary intake was standardized to an energy-adjusted worldwide representative diet database from eleven populations around the world, which was then multiplied by the literature-derived inflammatory effect score for each DII component and summed across all components to obtain the overall energy-adjusted score (E-DIITM). E-DII values can range from −8.87 (very anti-inflammatory diet) to +7.98 (very pro-inflammatory diet) [54]. For our study, we had access to 31 food parameters—alcohol, vitamin B12, vitamin B6, ß-carotene, caffeine, carbohydrates, cholesterol, energy, total fat, fiber, folic acid, iron, magnesium, monounsaturated fats, niacin, n-3 fatty acid, n-6 fatty acid, onion, protein, polyunsaturated fats, riboflavin, saturated fats, selenium, thiamin, trans fat, vitamin A, vitamin C, vitamin D, vitamin E, zinc, green/black tea.

2.4.5. Ferric Reducing Ability of Plasma Score

The dietary antioxidant capacity was determined using the Antioxidant Food Table that measures the antioxidant content of over 3100 types of foods and beverages using a Ferric Reducing Ability of Plasma (FRAP) assay [56]. The FRAP assay determines the antioxidant capacity of individual food items to reduce ferric iron (Fe3+) to ferrous iron (Fe2+) [57] and has been widely used in nutritional science [58]. For each participant, a FRAP score was calculated, taking the FRAP value of every type of food derived from the Antioxidant Food Table (mmol/100 g) and multiplying it by the consumption frequency. These values were summed across all dietary sources of antioxidants, representing the total dietary antioxidant capacity.

2.4.6. NOVA Classification

The NOVA classification (a name not an acronym) was used to assess the contribution of ultra-processed foods to the total dietary energy intake. This classification, developed by Monteiro and collaborators [59,60], categorizes foods and beverages according to their level of processing in four groups—Group 1, unprocessed or minimally processed foods (i.e., fresh fruits and vegetables, whole grains, legumes, eggs); Group 2, culinary ingredients (i.e., sugar, salt, oils); Group 3, processed foods (i.e., canned fruits, vegetables and legumes, dried, smoked, salted or sweetened meat, fish and nuts); Group 4, ultra-processed foods (i.e., soft drinks, sweet and salty snacks, commercial breads, cereals, flavored yogurts). For our study, foods and beverages were categorized by 3 registered dietitians. Caloric intake from ultra-processed foods (Group 4) was calculated as a percentage of the total daily energy intake.

2.5. Statistical Analysis

Distribution of variables was evaluated using the Kolmogorov-Smirnov test. Nutritional scores were classified into tertiles according to adherence levels. Crude and adjusted multivariate logistic regression models tested the associations between dietary scores and metabolic outcomes by calculating odds ratio and 95% confidence intervals. Potentially confounding variables including gender and survival time were incorporated in the analysis for all the scores. Energy intake was included as a confounding variable for the scores for which energy is not taken into account when calculated (MEDAS, KIDMED, HDI, FRAP, NOVA classification). For inflammatory biomarkers, differences in mean values between groups were tested using the Student t-test or Mann-Whitney test. p values < 0.05 were considered statistically significant. Statistical analysis was performed using SPSS (IBM SPSS Statistics for Windows, Version 25, Armonk, NY: IBM Corp.).

3. Results

3.1. Descriptive Statistics

Table 1 provides a summary of participants’ characteristics. One participant was excluded because he did not meet the inclusion criteria for PETALE and five participants were excluded due to missing nutritional data. A total of 241 participants were included in the study, comprised of 156 adults (≥18 years old) and 85 children (<18 years old). The proportion of males was 49.4%. The median age at visit was 21.3 years and median time since the end of treatment was 12.9 years. Overall, about 1/3rd (32.4%) of participants were obese, 41.1% had dyslipidemia, 16.6% had insulin resistance and 12% had pre-hypertension or hypertension and 29% had ≥2 cardiometabolic complications (cut-off values defined in Supplementary Table S1).
The descriptive statistics for dietary scores are summarized in Table 2 and their distributions are presented in Figure 1. According to the mean MEDAS and KIDMED scores, 88% of adults and 46% of children adhered poorly to the MD, whereas 12% of adults and 51% of children had moderate adherence. No adult and only 4% of children strongly adhered to the MD. Adherence to the WHO recommendations, qualified using the HDI-2018 score, showed that 89 participants (36.9%) had poor adherence, 136 (56.4%) modest adherence and 16 (6.6%) strong adherence. The HEI-2015 score revealed that 52 participants (21.6%) had poor quality diet, 184 (76.3%) had a diet to be improved and 5 (2.1%) had a diet of good quality. The E-DII scores ranged from −4.80 (most anti-inflammatory score) to +3.23 (most pro-inflammatory score). The FRAP score was between 1.96 mmol/day (lower total antioxidant capacity) and 48.8 mmol/day (higher total antioxidant capacity). On average, ultra-processed foods accounted for more than half of participants’ total energy intake, with a maximum of 93.4%.

3.2. Association between Dietary Scores and Anthropometric and Metabolic Parameters

Our results show that a more inflammatory diet, estimated with the E-DII score, was positively associated with high HOMA-IR (tertile 2 vs. 1: OR: 2.667, p = 0.03) and low HDL-C (tertiles 2 and 3 vs. 1: OR: 2.359, p = 0.02) (Table 3). High consumption of ultra-processed foods was positively correlated with having low HDL-C (tertile 3 vs. 1: OR: 3.885, p = 0.004) and high TG (tertile 2 and 3 vs. 1: OR: 4.021, p = 0.03) (Table 4). In adults, there were tendencies for a protective association between a higher MEDAS score and high WC (tertile 2 vs. 1: OR: 0.374, p = 0.059) and low HDL-C (tertile 2 vs. 1: OR: 0.401, p = 0.063); however, these results did not reach statistical significance (Supplementary Table S2). In children, a better adherence to the KIDMED was inversely associated with high SBP (tertiles 2 and 3 vs. 1: OR: 0.193, p = 0.05) (Supplementary Table S3). Finally, there was no association between adherence to the HDI-2018, HEI-2015 and FRAP scores and anthropometric and metabolic parameters (Supplementary Tables S4–S6).
Assessing the associations between diet and cardiometabolic complications revealed that a more pro-inflammatory diet was associated with an increased risk of having two or more risk factors (tertile 2 vs. 1: OR: 2.506, p = 0.01 and tertiles 2 and 3 vs. 1: OR: 2.076, p = 0.03) (Table 5). Similar results were observed when risk factors were analyzed individually: a more pro-inflammatory diet was positively associated with insulin resistance and hypertension and a higher consumption of ultra-processed foods was associated with dyslipidemia, but results were not statistically significant (Supplementary Tables S7–S10).

3.3. Association between Dietary Scores and Inflammatory Biomarkers

Participants who had a better adherence to the HEI-2015 score had lower level of TNF-α (tertile 3: 1.99 pg/mL vs. tertile 1: 2.28 pg/mL, p = 0.01), while levels were higher in those having a more inflammatory diet (tertile 3: 2.89 pg/mL vs. tertile 1: 2.10 pg/mL, p = 0.07), without reaching statistical significance (Supplementary Table S11). Next, the group was stratified according to participants’ obesity status (Figure 2). In non-obese participants, TNF-α levels were lower in those with higher HEI-2015 and KIDMED scores (tertile 3: 1.98 pg/mL vs. tertile 1: 2.23 pg/mL, p = 0.049 and tertile 2: 1.83 pg/mL vs. tertile 1: 2.52 pg/mL, p = 0.049, respectively). An inverse trend was observed with a greater proportion of ultra-processed foods (tertile 3: 2.36 pg/mL vs. tertile 1: 1.97 pg/mL, p = 0.06) (Figure 2). There was no effect of the scores in obese participants only.
Adults with a better adherence to the MD had higher levels of adiponectin (tertile 3: 19.41 ng/mL vs. tertile 1: 14.10 ng/mL, p = 0.004) (Supplementary Table S12). Similar differences according to the MEDAS score were found in both non-obese and obese adults but were not observed in children with the KIDMED score (Figure 2). In obese participants, adiponectin levels were lower with a pro-inflammatory diet (tertile 3: 11.44 ng/mL vs. tertile 1: 16.77 ng/mL, p = 0.044) and were higher with a better adherence to HDI-2018 scores (tertile 3: 15.76 ng/mL vs. tertile 1: 11.22 ng/mL, p = 0.044) (Figure 2).
Differences in IL-6 levels were observed only when obese and non-obese participants were analyzed separately (Supplementary Tables S13–S15). IL-6 levels were higher among obese and non-obese participants who consumed more ultra-processed foods (tertile 3: 0.83 pg/mL vs. tertile 2: 0.65 pg/mL, p = 0.04 and tertile 3: 0.77 pg/mL vs. tertile 2: 0.34 pg/mL, p = 0.004, respectively) (Supplementary Tables S14 and S15). Also, non-obese participants who had a better adherence to the HDI-2018 score had lower IL-6 levels (tertile 3: 0.35 pg/mL vs. tertile 1: 0.55 pg/mL, p = 0.02) (Supplementary Table S15). No statistical differences were found in the levels of CRP and leptin according to dietary scores (data not shown).

4. Discussion

We found that survivors of cALL of the PETALE cohort adhered poorly to the MD, had a modest adherence to the WHO recommendations and, according to the HEI-2015 score, the quality of their diet had to be improved. On average, more than half of participants’ daily energy intake was provided by ultra-processed foods. We also found that adherence to dietary scores was associated with several cardiometabolic outcomes, namely HDL-C, triglycerides, HOMA-IR, blood pressure and accumulating cardiometabolic risk factors. Diet quality also influenced circulating TNF-α and adiponectin levels.
It is well documented that, in the general population, the adherence to dietary guidelines and the quality of diet are sub-optimal [61]. It appears that survivors of childhood cancer are no exception. Several studies have demonstrated that cALL survivors adhere poorly to dietary recommendations [32,33,34]. By using 7 validated dietary scores, our study complements these observations. The use of dietary scores assesses, through a holistic approach, both quality and variety of diet. In our population, a large proportion of total caloric intake was provided by ultra-processed foods and adherence to the MD and the WHO recommendations was generally poor. Our results are consistent with data observed in previous studies, showing that survivors consume a high intake of free sugars, processed and refined foods, sodium and few fruits and vegetables [32,33]. Given that childhood cancer survivors are at high risk of metabolic and cardiovascular diseases [9,14] and of secondary cancer [62], adherence to healthy dietary patterns should be promoted in this population.
In our study, a better adherence to the MEDAS score was inversely associated with the risk of having low HDL-C, whereas positive associations were found with a more pro-inflammatory diet (E-DII score) and higher intake of ultra-processed foods. Previously, our group has highlighted the influence of nutrient and food group intakes on the risk of having low HDL-C in the PETALE cohort [39]. In Brazilian adults without cancer, a Traditional dietary pattern, characterized by a high consumption of rice and legumes and a low consumption of red meat, fat and sugar was associated with higher HDL-C [27]. An inverse association was found between the E-DII score and HDL-C levels in an American adult population [63]. HDL particles play a protective role in cardiovascular health by their involvement in reverse cholesterol transport [64] and their anti-inflammatory [65], antioxidant [66] and anti-thrombotic properties [67]. Several dietary components can improve HDL function. For example, the polyphenols contained in olive oil can increase reverse cholesterol transport and particle size, promote better stability by reducing triglycerides content and improve redox status [68]. Also, high doses of eicosapentaenoic acid increase reverse cholesterol transport and improve HDL anti-inflammatory and antioxidant functions [69]. Based on our results and considering that cALL survivors are more likely to present with low HDL-C [70,71], the improvement of diet quality should become an important aspect of long-term care management.
We found that a greater contribution of ultra-processed foods to total energy intake was associated with having high triglycerides. While data on the relationship between consumption of ultra-processed foods and cardiometabolic outcomes are growing [72], their impact on triglyceride levels remains uncertain [73]. Nonetheless, circulating levels of triglycerides are an independent risk factor for cardiovascular disease [74]. Also, low HDL-C levels were associated with high levels of triglycerides in previous studies [75,76]. Compared with the general population, survivors are eight times more likely to die from cardiovascular-related disease [77], which argues for a reduction of ultra-processed food consumption.
Participants consuming a more pro-inflammatory diet, measured with the E-DII score, were at higher risk of having a high HOMA-IR, an indicator of insulin resistance. Diet is an important contributor in the development of type 2 diabetes and insulin resistance [78] and other inflammation-related diseases [79]. Dietary components can exert pro-inflammatory or anti-inflammatory effects, which may influence the risk of inflammatory diseases, among other atherosclerosis [79]. Previous studies have shown that the DII score is associated with increased inflammatory biomarkers [80], incidence of cardiovascular disease [81], some cancers [82,83] and adiposity measures [84]. In a cross-sectional study of 2975 Iranian adults, the association between the DII score and the risk of glucose intolerance disorders could not be demonstrated, although trends were found between a higher DII and fasting blood glucose and HOMA-IR [85]. Likewise, a Western diet typically rich in pro-inflammatory foods, has been associated with altered glucose metabolism, insulin resistance and cardiovascular diseases [86,87]. More studies are needed to clearly assess if and how a “pro-inflammatory diet” can contribute to the development of insulin resistance and type 2 diabetes, especially in populations of childhood cancer survivors who have been exposed to high levels of inflammation and oxidative stress during their treatments.
In our cohort, a better adherence to the KIDMED and HDI-2018 scores was negatively associated with the risk of having pre-hypertension/hypertension and a more inflammatory diet was associated with an increased risk. Similarly, in a cohort of Brazilian adults, there was an inverse association between a diet rich in fruits, vegetables, legumes, whole grains and fish and high systolic blood pressure [27]. However, no relation between blood pressure and the adherence to the MD was found in adolescents [88]. We previously demonstrated that participants of the PETALE cohort were at increased risk of pre-hypertension and hypertension compared to the general population (relative risk of 2.59) [9]. While the underlying mechanisms remain misunderstood, the exposure of the cardiovascular system at an early age to the toxic effects of chemotherapeutic agents and to radiotherapy could cause endothelial damage [89]. Clearly, finding nutritional avenues to alleviate this side effect in the long term would benefit this population.
Although we found trends for associations between several dietary scores and indicators of adiposity (body mass index (BMI) and waist circumference), statistical significance was never achieved, perhaps owing to our limited sample size. In the literature, such associations are inconsistent. In a 6-year longitudinal study, better adherence to a MD was associated with lower waist circumference [90] but another study in adult women found no association [91]. In children, good adherence to the KIDMED score resulted in a 30% decreased odds of being overweight or obese [88]. In a cohort of 2967 adults, consumption of ultra-processed foods was associated with in increased risk of overweight and obesity [92]. However, in children, there was no association between the HEI-2015 score and BMI [93]. The causes of obesity are complex and multifactorial. Not only can the quantitative and qualitative aspects of diet have an impact, but other factors such as physical activity [94], sleeping habits [95] and genetics [96], contribute to maintaining body weight via the regulation of metabolic and endocrine processes. Although it appears intuitive, the contribution of diet quality in the maintenance of body weight and adiposity after childhood cancer remains to be confirmed.
Abdominal obesity is recognized as a risk factor for cardiovascular disease and type 2 diabetes [97]. It is characterized by increased adipose tissue surrounding the intra-abdominal organs. As a hormonally active tissue, visceral adipose tissue releases different bioactive molecules and hormones, such as adiponectin, leptin, TNF-α and IL-6. In our cohort of cALL survivors, we found associations between dietary scores and the inflammatory biomarkers TNF-α, IL-6 and adiponectin, while none was found for leptin and CRP. TNF-α is associated with low-grade inflammation, possibly leading to insulin resistance and diabetes [98] and contributes to the pathogenesis of atherosclerosis [99]. In non-obese participants of our cohort, greater adherence to the HEI-2015 and KIDMED scores was associated with lower TNF-α levels. Conversely, there was a positive trend observed with eating a more inflammatory diet or ultra-processed foods. In parallel, no statistically significant difference was found in obese participants, although a similar trend was found for HEI-2015 adherence. In the literature, a higher E-DII score has been associated with greater TNF-α levels in adolescents [80]. In adults with type 2 diabetes or at least 3 risk factors (hypertension, dyslipidemia or a family history coronary heart disease), a nutritional intervention based on the MD led to lower plasma concentrations of TNF receptors [100]. We also found higher IL-6 levels in relation to ultra-processed foods in both obese and non-obese participants and lower IL-6 with higher HDI-2018 score in non-obese. IL-6 has been identified as a marker for metabolic disorders and cardiovascular disease, although its exact in vivo pathophysiological significance remains unknown [101]. Some literature also supports a link between circulating IL-6 and diet. In women, consumption of trans fatty acids was positively associated with IL-6 levels but only in participants with higher BMI [102]. In populations at high cardiometabolic risk, an MD supplemented with olive oil or nuts reduced IL-6 levels [103]. Additionally, adiponectin produced by the adipose tissue, is responsible for the modulation of several metabolic processes such as glucose hemostasis and fatty acid oxidation, in addition to having anti-inflammatory properties [104,105]. Circulating levels of adiponectin have been inversely associated with the metabolic syndrome [106,107]. In our cohort, participants with a better adherence to the MD had higher adiponectin levels and this was observed in both obese and non-obese adults. Additional differences were found only in obese participants, namely with the HDI-2018 and E-DII scores. Similarly, a literature review of 10 studies on dietary patterns and adiponectin levels concluded that adherents to healthy dietary patterns have higher levels of circulating adiponectin [108]. The reasons explaining why, in our study, different results were observed in obese and non-obese participants are unclear. One can speculate that, with greater adiposity, the contribution of diet to one’s inflammatory state could be more or less important, depending on the pathway. Nonetheless, the small sample size of the sub-group might have precluded reaching statistical significance.
In our study, no associations between diet quality and the biomarkers leptin and CRP were found. Leptin is an important modulator of food intake and energy balance. Circulating leptin is strongly associated with BMI and the degree of adiposity [109]. Leptin levels were found higher in female cALL survivors compared to controls, which was not observed in male survivors [110]. However, leptin levels were not associated with dietary habits in another cohort [111]. CRP is a biomarker of the inflammatory status and a predictor of cardiovascular events [112]. CRP was associated with trans fatty acids in obese women [102] and was reduced following an MD intervention [103]. While the literature on diet quality and biomarkers of inflammation is divergent, further studies are needed to elucidate the role of diet on inflammatory processes in survivors of cALL.
The PETALE cohort is mostly comprised of AYA cALL survivors, a population that is understudied and that faces particular challenges in terms of compliance with treatment [113,114] and ability to follow dietary recommendations. In particular, low consumption of fruits and vegetables [32,115], fiber [34] and high intakes of high-fat foods [115] have been reported in AYA cancer survivors. Besides, high intakes of refined grains [61,116], empty calories [116] fruit juice and food high in sugar and fat [61] were noted in children and adolescents from the general population. Therefore, it is of high interest to study dietary and lifestyle habits in the very specific population of AYA cancer survivors.
A strength of our study is the use of numerous dietary scores to evaluate the quality of diet and its association with cardiometabolic health in survivors of cALL. The use of a validated food frequency questionnaire tailored for our population and the thorough biochemical and clinical characterization of the PETALE cohort are other strengths. One important study limitation is the sample size, which reduce the likelihood of obtaining more statistically significant associations. Also, it is known that questionnaires are associated with social approval and desirability biases [117,118] and that self-assessment of diet makes measurement error inevitable. While the MD can be assessed by several scores and a posteriori analyses, only the MEDAS and KIDMED scores were used in our study. Moreover, given the exploratory nature of the study, p values were not adjusted for multiple testing. It is possible that other confounding variables were not measured or accounted for in the analysis. Validation of our findings in other cohorts of cALL survivors is necessary. The lack of a non-cancer control group is another study limitation that prevents comparison with the general population. Finally, our study findings identified associations and do not explain how the different components of diet can modulate cardiometabolic health outcomes.

5. Conclusions

Our study showed that adolescent and young adult survivors of cALL do not have good adherence to dietary guidelines. Our results support a beneficial role for a high-quality diet on survivors’ cardiometabolic health, reflected by adherence to the MD, the WHO recommendations, the American Dietary Guidelines, as well as by a limited consumption of pro-inflammatory and ultra-processed foods. A better understanding of how diet and dietary components can affect the health of cALL survivors will allow the development of tailored recommendations and nutritional strategies for this high-risk population.

Supplementary Materials

The following are available online at https://0-www-mdpi-com.brum.beds.ac.uk/2072-6643/12/7/2137/s1, Table S1: Cut-off values and definitions of cardiometabolic outcomes, Table S2: Associations between adherence to the MEDAS score and anthropometric and metabolic parameters, Table S3: Associations between adherence to the KIDMED score and anthropometric and metabolic parameters, Table S4: Associations between adherence to the HDI-2018 score and anthropometric and metabolic parameters, Table S5: Associations between adherence to the HEI-2015 score and anthropometric and metabolic parameters, Table S6: Associations between adherence to the FRAP score and anthropometric and metabolic parameters, Table S7; Association between adherence to nutritional scores and insulin resistance; Table S8: Association between adherence to nutritional scores and dyslipidemia, Table S9: Association between adherence to nutritional scores and obesity. Table S10: Association between adherence to nutritional scores and hypertension, Table S11: Association between adherence to nutritional scores and TNF-α levels in all participants, Table S12: Association between adherence to nutritional scores and adiponectin levels in all participants, Table S13: Association between adherence to nutritional scores and IL-6 levels in all participants, Table S14: Association between adherence to nutritional scores and IL-6 levels in obese participants, Table S15: Association between adherence to nutritional scores and IL-6 levels in non-obese participants.

Author Contributions

Conceptualization, C.L., D.S., E.L. and V.M.; methodology, V.M., E.L., S.M., N.S., J.R.H. and S.B.; formal analysis, S.B., S.M., N.S., J.R.H. and E.T.; investigation, S.M., V.M. and S.B.; writing—original draft preparation, S.B., S.M., E.T and V.M.; writing—review and editing, V.M., E.L., D.S., C.L., N.S., J.R.H. and E.T.; supervision, V.M.; project administration, D.S., C.L., E.L. and V.M.; funding acquisition, D.S., C.L., E.L and V.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Institute of Cancer Research (ICR) of the Canadian Institutes of Health Research (CIHR), in collaboration with C17 Council, Canadian Cancer Society (CCS), Cancer Research Society (CRS), Garron Family Cancer Centre at the Hospital for Sick Children, Ontario Institute for Cancer Research (OICR) and Pediatric Oncology Group of Ontario (POGO), grant number: TCF 118694, by the J.A. DeSève Research Chair in Nutrition, the Fonds de Recherche du Québec en Santé and by a Transition Grant from the Cole Foundation.

Acknowledgments

We wish to thank the cALL survivors that generously gave of their time to be part of the PETALE study.

Conflicts of Interest

The authors declare no conflict of interest.

Disclosure

James R. Hébert owns controlling interest in Connecting Health Innovations LLC (CHI), a company that has licensed the right to his invention of the dietary inflammatory index (DII®) from the University of South Carolina in order to develop computer and smart phone applications for patient counseling and dietary intervention in clinical settings. Nitin Shivappa is an employee of CHI.

References

  1. Canadian Vital Death Statistics Database (CVSD) linked to Discharge Abstract Database (DAD) and National Ambulatory Care Reporting System (NACRS). Available online: https://www.statcan.gc.ca/eng/rdc/cvsd-nacrs (accessed on 3 March 2020).
  2. Government of Canada. Cancer in Children in Canada (0–14 Years). Available online: https://www.canada.ca/en/public-health/services/chronic-diseases/cancer/cancer-children-canada-0-14-years.html (accessed on 3 March 2020).
  3. Ness, K.K.; Armenian, S.H.; Kadan-Lottick, N.; Gurney, J.G. Adverse effects of treatment in childhood acute lymphoblastic leukemia: General overview and implications for long-term cardiac health. Expert Rev. Hematol. 2011, 4, 185–197. [Google Scholar] [CrossRef] [Green Version]
  4. Pui, C.H.; Evans, W.E. A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin. Hematol. 2013, 50, 185–196. [Google Scholar] [CrossRef] [Green Version]
  5. Mazzucco, W.; Cusimano, R.; Mazzola, S.; Rudisi, G.; Zarcone, M.; Marotta, C.; Graziano, G.; D’Angelo, P.; Vitale, F. Childhood and Adolescence Cancers in the Palermo Province (Southern Italy): Ten Years (2003–2012) of Epidemiological Surveillance. Int. J. Environ. Res. Public Health 2018, 15, 1344. [Google Scholar] [CrossRef] [Green Version]
  6. Phillips, S.M.; Padgett, L.S.; Leisenring, W.M.; Stratton, K.K.; Bishop, K.; Krull, K.R.; Alfano, C.M.; Gibson, T.M.; de Moor, J.S.; Hartigan, D.B.; et al. Survivors of childhood cancer in the United States: Prevalence and burden of morbidity. Cancer Epidemiol. Biomark. Prev. 2015, 24, 653–663. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Oeffinger, K.C.; Mertens, A.C.; Sklar, C.A.; Kawashima, T.; Hudson, M.M.; Meadows, A.T. Chronic Health Conditions in Adult Survivors of Childhood Cancer. N. Engl. J. Med. 2006, 355, 1572–1582. [Google Scholar] [CrossRef]
  8. Mody, R.; Li, S.; Dover, D.C.; Sallan, S.; Leisenring, W.; Oeffinger, K.C.; Yasui, Y.; Robison, L.L.; Neglia, J.P. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Blood 2008, 111, 5515–5523. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Levy, E.; Samoilenko, M.; Morel, S.; England, J.; Amre, D.; Bertout, L.; Drouin, S.; Laverdiere, C.; Krajinovic, M.; Sinnett, D.; et al. Cardiometabolic Risk Factors in Childhood, Adolescent and Young Adult Survivors of Acute Lymphoblastic Leukemia—A Petale Cohort. Sci. Rep. 2017, 7, 17684. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Janiszewski, P.M.; Oeffinger, K.C.; Church, T.S.; Dunn, A.L.; Eshelman, D.A.; Victor, R.G.; Brooks, S.; Turoff, A.J.; Sinclair, E.; Murray, J.C.; et al. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J. Clin. Endocrinol. Metab. 2007, 92, 3816–3821. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Chueh, H.W.; Yoo, J.H. Metabolic syndrome induced by anticancer treatment in childhood cancer survivors. Ann. Pediatr. Endocrinol. Metab. 2017, 22, 82–89. [Google Scholar] [CrossRef] [Green Version]
  12. Meacham, L.R.; Sklar, C.A.; Li, S.; Liu, Q.; Gimpel, N.; Yasui, Y.; Whitton, J.A.; Stovall, M.; Robison, L.L.; Oeffinger, K.C. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: A report for the childhood cancer survivor study. Arch Intern. Med. 2009, 169, 1381–1388. [Google Scholar] [CrossRef] [Green Version]
  13. Meacham, L.R.; Chow, E.J.; Ness, K.K.; Kamdar, K.Y.; Chen, Y.; Yasui, Y.; Oeffinger, K.C.; Sklar, C.A.; Robison, L.L.; Mertens, A.C. Cardiovascular risk factors in adult survivors of pediatric cancer—A report from the childhood cancer survivor study. Cancer Epidemiol. Biomark. Prev. 2010, 19, 170–181. [Google Scholar] [CrossRef] [Green Version]
  14. Rosen, G.P.; Nguyen, H.T.; Shaibi, G.Q. Metabolic syndrome in pediatric cancer survivors: A mechanistic review. Pediatr. Blood Cancer 2013, 60, 1922–1928. [Google Scholar] [CrossRef] [PubMed]
  15. Westerink, N.L.; Nuver, J.; Lefrandt, J.D.; Vrieling, A.H.; Gietema, J.A.; Walenkamp, A.M. Cancer treatment induced metabolic syndrome: Improving outcome with lifestyle. Crit. Rev. Oncol. Hematol. 2016, 108, 128–136. [Google Scholar] [CrossRef] [PubMed]
  16. Touchefeu, Y.; Montassier, E.; Nieman, K.; Gastinne, T.; Potel, G.; Bruley des Varannes, S.; Le Vacon, F.; de La Cochetiere, M.F. Systematic review: The role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis—Current evidence and potential clinical applications. Aliment. Pharmacol. Ther. 2014, 40, 409–421. [Google Scholar] [CrossRef] [PubMed]
  17. Van Vliet, M.J.; Tissing, W.J.; Dun, C.A.; Meessen, N.E.; Kamps, W.A.; de Bont, E.S.; Harmsen, H.J. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin. Infect. Dis. 2009, 49, 262–270. [Google Scholar] [CrossRef] [Green Version]
  18. Zwielehner, J.; Lassl, C.; Hippe, B.; Pointner, A.; Switzeny, O.J.; Remely, M.; Kitzweger, E.; Ruckser, R.; Haslberger, A.G. Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS ONE 2011, 6, e28654. [Google Scholar] [CrossRef] [Green Version]
  19. Mozaffarian, D.; Benjamin, E.J.; Go, A.S.; Arnett, D.K.; Blaha, M.J.; Cushman, M.; Ferranti, S.D.; Després, J.P. Heart Disease and Stroke Statistics—2015 Update. A Report From the American Heart Association. Circulation 2015, 131, e29–e32. [Google Scholar]
  20. Atkins, J.L.; Whincup, P.H.; Morris, R.W.; Lennon, L.T.; Papacosta, O.; Wannamethee, S.G. High diet quality is associated with a lower risk of cardiovascular disease and all-cause mortality in older men. J. Nutr. 2014, 144, 673–680. [Google Scholar] [CrossRef]
  21. Mora, S.; Lee, I.-M.; Buring, J.E.; Ridker, P.M. Association of Physical Activity and Body Mass Index with Novel and Traditional Cardiovascular Biomarkers in Women. JAMA 2006, 295, 1412–1419. [Google Scholar] [CrossRef] [Green Version]
  22. Kodama, S.; Saito, K.; Tanaka, S.; Maki, M.; Yachi, Y.; Asumi, M.; Sugawara, A.; Totsuka, K.; Shimano, H.; Ohashi, Y.; et al. Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women. JAMA 2009, 301, 2024–2035. [Google Scholar] [CrossRef] [Green Version]
  23. Estruch, R.; Ros, E.; Salas-Salvado, J.; Covas, M.I.; Corella, D.; Aros, F.; Gomez-Gracia, E.; Ruiz-Gutierrez, V.; Fiol, M.; Lapetra, J.; et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 2013, 368, 1279–1290. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Mente, A.; de Koning, L.; Shannon, H.S.; Anand, S.S. A Systematic Review of the Evidence Supporting a Causal Link Between Dietary Factors and Coronary Heart Disease. Arch. Intern. Med. 2009, 169, 659–669. [Google Scholar] [CrossRef] [Green Version]
  25. Cunha, C.M.; Costa, P.R.F.; de Oliveira, L.P.M.; Queiroz, V.A.O.; Pitangueira, J.C.D.; Oliveira, A.M. Dietary patterns and cardiometabolic risk factors among adolescents: Systematic review and meta-analysis. Br. J. Nutr. 2018, 119, 859–879. [Google Scholar] [CrossRef]
  26. Shang, X.; Li, Y.; Xu, H.; Zhang, Q.; Liu, A.; Ma, G. The Clustering of Low Diet Quality, Low Physical Fitness, and Unhealthy Sleep Pattern and Its Association with Changes in Cardiometabolic Risk Factors in Children. Nutrients 2020, 12, 591. [Google Scholar] [CrossRef] [Green Version]
  27. Castro, M.A.; Baltar, V.T.; Marchioni, D.M.; Fisberg, R.M. Examining associations between dietary patterns and metabolic CVD risk factors: A novel use of structural equation modelling. Br. J. Nutr. 2016, 115, 1586–1597. [Google Scholar] [CrossRef] [Green Version]
  28. Papadaki, A.; Johnson, L.; Toumpakari, Z.; England, C.; Rai, M.; Toms, S.; Penfold, C.; Zazpe, I.; Martinez-Gonzalez, M.A.; Feder, G. Validation of the English Version of the 14-Item Mediterranean Diet Adherence Screener of the PREDIMED Study, in People at High Cardiovascular Risk in the UK. Nutrients 2018, 10, 138. [Google Scholar] [CrossRef] [Green Version]
  29. Schroder, H.; Fito, M.; Estruch, R.; Martinez-Gonzalez, M.A.; Corella, D.; Salas-Salvado, J.; Lamuela-Raventos, R.; Ros, E.; Salaverria, I.; Fiol, M.; et al. A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. J. Nutr. 2011, 141, 1140–1145. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Marshall, S.; Burrows, T.; Collins, C.E. Systematic review of diet quality indices and their associations with health-related outcomes in children and adolescents. J. Hum. Nutr. Diet 2014, 27, 577–598. [Google Scholar] [CrossRef] [Green Version]
  31. Lazarou, C.; Newby, P.K. Use of dietary indexes among children in developed countries. Adv. Nutr. 2011, 2, 295–303. [Google Scholar] [CrossRef] [Green Version]
  32. Belle, F.; Wengenroth, L.; Weiss, A.; Sommer, G.; Beck Popovic, M.; Ansari, M.; Bochud, M.; Kuehni, C.; Swiss Paediatric Oncology Group. Low adherence to dietary recommendations in adult childhood cancer survivors. Clin. Nutr. 2017, 36, 1266–1274. [Google Scholar] [CrossRef]
  33. Robien, K.; Ness, K.K.; Klesges, L.M.; Baker, K.S.; Gurney, J.G. Poor adherence to dietary guidelines among adult survivors of childhood acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol. 2008, 30, 815–822. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Berdan, C.A.; Tangney, C.C.; Scala, C.; Stolley, M. Childhood cancer survivors and adherence to the American Cancer Society Guidelines on Nutrition and Physical Activity. J. Cancer Surviv. 2014, 8, 671–679. [Google Scholar] [CrossRef] [PubMed]
  35. Zhang, F.F.; Saltzman, E.; Kelly, M.J.; Liu, S.; Must, A.; Parsons, S.K.; Roberts, S.B. Comparison of childhood cancer survivors’ nutritional intake with US dietary guidelines. Pediatr. Blood Cancer 2015, 62, 1461–1467. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Landy, D.C.; Lipsitz, S.R.; Kurtz, J.M.; Hinkle, A.S.; Constine, L.S.; Adams, M.J.; Lipshultz, S.E.; Miller, T.L. Dietary quality, caloric intake, and adiposity of childhood cancer survivors and their siblings: An analysis from the cardiac risk factors in childhood cancer survivors study. Nutr. Cancer 2013, 65, 547–555. [Google Scholar] [CrossRef] [PubMed]
  37. Tylavsky, F.A.; Smith, K.; Surprise, H.; Garland, S.; Yan, X.; McCammon, E.; Hudson, M.M.; Pui, C.H.; Kaste, S.C. Nutritional intake of long-term survivors of childhood acute lymphoblastic leukemia: Evidence for bone health interventional opportunities. Pediatr. Blood Cancer 2010, 55, 1362–1369. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Marcoux, S.; Drouin, S.; Laverdiere, C.; Alos, N.; Andelfinger, G.U.; Bertout, L.; Curnier, D.; Friedrich, M.G.; Kritikou, E.A.; Lefebvre, G.; et al. The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors. Pediatr. Blood Cancer 2017, 64, e26361. [Google Scholar] [CrossRef]
  39. Morel, S.; Amre, D.; Teasdale, E.; Caru, M.; Laverdiere, C.; Krajinovic, M.; Sinnett, D.; Curnier, D.; Levy, E.; Marcil, V. Dietary Intakes Are Associated with HDL-Cholesterol in Survivors of Childhood Acute Lymphoblastic Leukaemia. Nutrients 2019, 11, 2977. [Google Scholar] [CrossRef] [Green Version]
  40. Genest, J.; McPherson, R.; Frohlich, J.; Anderson, T.; Campbell, N.; Carpentier, A.; Couture, P.; Dufour, R.; Fodor, G.; Francis, G.A.; et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult—2009 recommendations. Can. J. Cardiol. 2009, 25, 567–579. [Google Scholar] [CrossRef] [Green Version]
  41. Grundy, S.M.; Brewer, H.B., Jr.; Cleeman, J.I.; Smith, S.C., Jr.; Lenfant, C.; American Heart, A.; National Heart, L.; Blood, I. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109, 433–438. [Google Scholar] [CrossRef] [Green Version]
  42. De Jesus, J.M. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. Pediatrics 2011, 128, S213–S256. [Google Scholar] [CrossRef] [Green Version]
  43. Morel, S.; Portolese, O.; Chertouk, Y.; Leahy, J.; Bertout, L.; Laverdiere, C.; Krajinovic, M.; Sinnett, D.; Levy, E.; Marcil, V. Development and relative validation of a food frequency questionnaire for French-Canadian adolescent and young adult survivors of acute lymphoblastic leukemia. Nutr. J. 2018, 17, 45. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Martinez-Gonzalez, M.A.; Garcia-Arellano, A.; Toledo, E.; Salas-Salvado, J.; Buil-Cosiales, P.; Corella, D.; Covas, M.I.; Schroder, H.; Aros, F.; Gomez-Gracia, E.; et al. A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: The PREDIMED trial. PLoS ONE 2012, 7, e43134. [Google Scholar] [CrossRef] [Green Version]
  45. Serra-Majem, L.; Ribas, L.; Ngo, J.; Ortega, R.M.; Garcia, A.; Perez-Rodrigo, C.; Aranceta, J. Food, youth and the Mediterranean diet in Spain. Development of KIDMED, Mediterranean Diet Quality Index in children and adolescents. Public Health Nutr. 2004, 7, 931–935. [Google Scholar] [CrossRef] [PubMed]
  46. Altavilla, C.; Caballero-Perez, P. An update of the KIDMED questionnaire, a Mediterranean Diet Quality Index in children and adolescents. Public Health Nutr. 2019, 22, 2543–2547. [Google Scholar] [CrossRef]
  47. Amine, E.K.; Baba, N.H.; Belhadj, M.; Deurenberg-Yap, M.; Djazayery, A. Diet, Nutrition and the Prevention of Chronic Diseases. World Health Organization: Geneva, Switzerland, 2003. [Google Scholar]
  48. World Health Organization. Healthy Diet. Available online: https://www.who.int/news-room/fact-sheets/detail/healthy-diet (accessed on 4 March 2020).
  49. Kanauchi, M.; Kanauchi, K. The World Health Organization’s Healthy Diet Indicator and its associated factors: A cross-sectional study in central Kinki, Japan. Prev. Med. Rep. 2018, 12, 198–202. [Google Scholar] [CrossRef]
  50. 2015–2020 Dietary Guidelines for Americans, 8th ed.; U.S. Department of Health and Human Services, U.S. Department of Agriculture: Washington, DC, USA, 2015.
  51. Krebs-Smith, S.M.; Pannucci, T.E.; Subar, A.F.; Kirkpatrick, S.I.; Lerman, J.L.; Tooze, J.A.; Wilson, M.M.; Reedy, J. Update of the Healthy Eating Index: HEI-2015. J. Acad. Nutr. Diet 2018, 118, 1591–1602. [Google Scholar] [CrossRef] [Green Version]
  52. Kirkpatrick, S.I.; Reedy, J.; Krebs-Smith, S.M.; Pannucci, T.E.; Subar, A.F.; Wilson, M.M.; Lerman, J.L.; Tooze, J.A. Applications of the Healthy Eating Index for Surveillance, Epidemiology, and Intervention Research: Considerations and Caveats. J. Acad. Nutr. Diet 2018, 118, 1603–1621. [Google Scholar] [CrossRef]
  53. Basiotis, P.P.; Carlson, A.; Gerrior, S.A.; Juan, W.Y.; Lino, M. The Healthy Eating Index: 1999–2000; U.S. Department of Agriculture, Center for Nutrition Policy and Promotion: Washington, DC, USA, 2002.
  54. Shivappa, N.; Steck, S.E.; Hurley, T.G.; Hussey, J.R.; Hebert, J.R. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014, 17, 1689–1696. [Google Scholar] [CrossRef] [Green Version]
  55. Shivappa, N.; Steck, S.E.; Hurley, T.G.; Hussey, J.R.; Ma, Y.; Ockene, I.S.; Tabung, F.; Hebert, J.R. A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal Variation of Blood Cholesterol Study (SEASONS). Public Health Nutr. 2014, 17, 1825–1833. [Google Scholar] [CrossRef]
  56. Carlsen, M.H.; Halvorsen, B.L.; Holte, K.; Bohn, S.K.; Dragland, S.; Sampson, L.; Willey, C.; Senoo, H.; Umezono, Y.; Sanada, C.; et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr. J. 2010, 9, 3. [Google Scholar] [CrossRef]
  57. Benzie, I.F.F.; Strain, J.J. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay. Anal. Biochem. 1999, 239, 70–76. [Google Scholar] [CrossRef] [Green Version]
  58. Benzie, I.F.; Choi, S.W. Antioxidants in food: Content, measurement, significance, action, cautions, caveats, and research needs. Adv. Food Nutr. Res. 2014, 71, 1–53. [Google Scholar] [CrossRef]
  59. Monteiro, C.; Cannon, G.; Levy, R.B.; Claro, R.; Moubarac, J.-C.; Martins, A.P.; Louzada, M.L.; Baraldi, L.; Canella, D. The Food System. Ultra-processing. The big issue for nutrition, disease, health, well-being. World Nutr. 2012, 3, 527–569. [Google Scholar]
  60. Moubarac, J.C.; Parra, D.C.; Cannon, G.; Monteiro, C.A. Food Classification Systems Based on Food Processing: Significance and Implications for Policies and Actions: A Systematic Literature Review and Assessment. Curr. Obes. Rep. 2014, 3, 256–272. [Google Scholar] [CrossRef]
  61. Jessri, M.; Nishi, S.K.; L’Abbe, M.R. Assessing the nutritional quality of diets of Canadian children and adolescents using the 2014 Health Canada Surveillance Tool Tier System. BMC Public Health 2016, 16, 381. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Turcotte, L.M.; Whitton, J.A.; Friedman, D.L.; Hammond, S.; Armstrong, G.T.; Leisenring, W.; Robison, L.L.; Neglia, J.P. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort. J. Clin. Oncol. 2015, 33, 3568–3575. [Google Scholar] [CrossRef]
  63. Mazidi, M.; Shivappa, N.; Wirth, M.D.; Hebert, J.R.; Mikhailidis, D.P.; Kengne, A.P.; Banach, M. Dietary inflammatory index and cardiometabolic risk in US adults. Atherosclerosis 2018, 276, 23–27. [Google Scholar] [CrossRef]
  64. Marques, L.R.; Diniz, T.A.; Antunes, B.M.; Rossi, F.E.; Caperuto, E.C.; Lira, F.S.; Goncalves, D.C. Reverse Cholesterol Transport: Molecular Mechanisms and the Non-medical Approach to Enhance HDL Cholesterol. Front. Physiol. 2018, 9, 526. [Google Scholar] [CrossRef]
  65. Rye, K.A.; Barter, P.J. Cardioprotective functions of HDLs. J. Lipid. Res. 2014, 55, 168–179. [Google Scholar] [CrossRef] [Green Version]
  66. Soran, H.; Schofield, J.D.; Durrington, P.N. Antioxidant properties of HDL. Front. Pharmacol. 2015, 6, 222. [Google Scholar] [CrossRef] [Green Version]
  67. Camont, L.; Lhomme, M.; Rached, F.; Le Goff, W.; Negre-Salvayre, A.; Salvayre, R.; Calzada, C.; Lagarde, M.; Chapman, M.J.; Kontush, A. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: Relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities. Arter. Thromb Vasc. Biol. 2013, 33, 2715–2723. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Hernaez, A.; Fernandez-Castillejo, S.; Farras, M.; Catalan, U.; Subirana, I.; Montes, R.; Sola, R.; Munoz-Aguayo, D.; Gelabert-Gorgues, A.; Diaz-Gil, O.; et al. Olive oil polyphenols enhance high-density lipoprotein function in humans: A randomized controlled trial. Arter. Thromb Vasc. Biol. 2014, 34, 2115–2119. [Google Scholar] [CrossRef] [Green Version]
  69. Tanaka, N.; Ishida, T.; Nagao, M.; Mori, T.; Monguchi, T.; Sasaki, M.; Mori, K.; Kondo, K.; Nakajima, H.; Honjo, T.; et al. Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia. Atherosclerosis 2014, 237, 577–583. [Google Scholar] [CrossRef]
  70. Nottage, K.A.; Ness, K.K.; Li, C.; Srivastava, D.; Robison, L.L.; Hudson, M.M. Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia—From the St. Jude Lifetime Cohort. Br. J. Haematol. 2014, 165, 364–374. [Google Scholar] [CrossRef]
  71. Link, K.; Moell, C.; Garwicz, S.; Cavallin-Stahl, E.; Bjork, J.; Thilen, U.; Ahren, B.; Erfurth, E.M. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J. Clin. Endocrinol. Metab. 2004, 89, 5003–5012. [Google Scholar] [CrossRef]
  72. Poti, J.M.; Braga, B.; Qin, B. Ultra-processed Food Intake and Obesity: What Really Matters for Health-Processing or Nutrient Content? Curr. Obes. Rep. 2017, 6, 420–431. [Google Scholar] [CrossRef]
  73. Lavigne-Robichaud, M.; Moubarac, J.C.; Lantagne-Lopez, S.; Johnson-Down, L.; Batal, M.; Laouan Sidi, E.A.; Lucas, M. Diet quality indices in relation to metabolic syndrome in an Indigenous Cree (Eeyouch) population in northern Quebec, Canada. Public Health Nutr. 2018, 21, 172–180. [Google Scholar] [CrossRef] [Green Version]
  74. Kim, E.H.; Lee, J.B.; Kim, S.H.; Jo, M.-W.; Hwang, J.Y.; Bae, S.J.; Jung, C.H.; Lee, W.J.; Park, J.-Y.; Park, G.-M.; et al. Serum Triglyceride Levels and Cardiovascular Disease Events in Koreans. Cardiology 2015, 131, 228–235. [Google Scholar] [CrossRef]
  75. Chapman, M.J.; Ginsberg, H.N.; Amarenco, P.; Andreotti, F.; Boren, J.; Catapano, A.L.; Descamps, O.S.; Fisher, E.; Kovanen, P.T.; Kuivenhoven, J.A.; et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: Evidence and guidance for management. Eur. Heart J. 2011, 32, 1345–1361. [Google Scholar] [CrossRef] [Green Version]
  76. Langsted, A.; Jensen, A.M.R.; Varbo, A.; Nordestgaard, B.G. Low High-Density Lipoprotein Cholesterol to Monitor Long-Term Average Increased Triglycerides. J. Clin. Endocrinol. Metab. 2020, 105. [Google Scholar] [CrossRef] [PubMed]
  77. Armstrong, G.T.; Liu, Q.; Yasui, Y.; Neglia, J.P.; Leisenring, W.; Robison, L.L.; Mertens, A.C. Late mortality among 5-year survivors of childhood cancer: A summary from the Childhood Cancer Survivor Study. J. Clin. Oncol. 2009, 27, 2328–2338. [Google Scholar] [CrossRef] [Green Version]
  78. Sami, W.; Ansari, T.; Butt, N.S.; Hamid, M.R.A. Effect of diet on type 2 diabetes mellitus: A review. Int. J. Health Sci. 2017, 11, 65–71. [Google Scholar]
  79. Pahwa, R.; Goyal, A.; Bansal, P.; Jialal, I. Chronic Inflammation; StatPearls Publishing: Treasure Island, FL, USA, 2020; pp. 1–22. [Google Scholar]
  80. Shivappa, N.; Hebert, J.R.; Marcos, A.; Diaz, L.E.; Gomez, S.; Nova, E.; Michels, N.; Arouca, A.; Gonzalez-Gil, E.; Frederic, G.; et al. Association between dietary inflammatory index and inflammatory markers in the HELENA study. Mol. Nutr. Food Res. 2017, 61, 1600707. [Google Scholar] [CrossRef] [PubMed]
  81. Shivappa, N.; Godos, J.; Hebert, J.R.; Wirth, M.D.; Piuri, G.; Speciani, A.F.; Grosso, G. Dietary Inflammatory Index and Cardiovascular Risk and Mortality-A Meta-Analysis. Nutrients 2018, 10, 200. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Fowler, M.E.; Akinyemiju, T.F. Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes. Int. J. Cancer 2017, 141, 2215–2227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Shivappa, N.; Miao, Q.; Walker, M.; Hebert, J.R.; Aronson, K.J. Association Between a Dietary Inflammatory Index and Prostate Cancer Risk in Ontario, Canada. Nutr. Cancer 2017, 69, 825–832. [Google Scholar] [CrossRef] [PubMed]
  84. Mtintsilana, A.; Micklesfield, L.K.; Chorell, E.; Olsson, T.; Shivappa, N.; Hebert, J.R.; Kengne, A.P.; Goedecke, J.H. Adiposity Mediates the Association between the Dietary Inflammatory Index and Markers of Type 2 Diabetes Risk in Middle-Aged Black South African Women. Nutrients 2019, 11, 1246. [Google Scholar] [CrossRef] [Green Version]
  85. Moslehi, N.; Ehsani, B.; Mirmiran, P.; Shivappa, N.; Tohidi, M.; Hebert, J.R.; Azizi, F. Inflammatory Properties of Diet and Glucose-Insulin Homeostasis in a Cohort of Iranian Adults. Nutrients 2016, 8, 735. [Google Scholar] [CrossRef] [Green Version]
  86. Vlassara, H. Advanced glycation in health and disease: Role of the modern environment. Ann. N. Y. Acad. Sci. 2005, 1043, 452–460. [Google Scholar] [CrossRef]
  87. Vlassara, H.; Striker, G. Glycotoxins in the Diet Promote Diabetes and Diabetic Complications. Diabet. Complicat. 2007, 7, 235–241. [Google Scholar] [CrossRef]
  88. Mistretta, A.; Marventano, S.; Antoci, M.; Cagnetti, A.; Giogianni, G.; Nolfo, F.; Rametta, S.; Pecora, G.; Marranzano, M. Mediterranean diet adherence and body composition among Southern Italian adolescents. Obes. Res. Clin. Pract. 2017, 11, 215–226. [Google Scholar] [CrossRef] [PubMed]
  89. Lipshultz, S.E.; Adams, M.J.; Colan, S.D.; Constine, L.S.; Herman, E.H.; Hsu, D.T.; Hudson, M.M.; Kremer, L.C.; Landy, D.C.; Miller, T.L.; et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: Pathophysiology, course, monitoring, management, prevention, and research directions: A scientific statement from the American Heart Association. Circulation 2013, 128, 1927–1995. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  90. Tortosa, A.; Bes-Rastrollo, M.; Sanchez-Villegas, A.; Basterra-Gortari, F.J.; Nunez-Cordoba, J.M.; Martinez-Gonzalez, M.A. Mediterranean diet inversely associated with the incidence of metabolic syndrome: The SUN prospective cohort. Diabetes Care 2007, 30, 2957–2959. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  91. Li, Y.; Roswall, N.; Strom, P.; Sandin, S.; Adami, H.O.; Weiderpass, E. Mediterranean and Nordic diet scores and long-term changes in body weight and waist circumference: Results from a large cohort study. Br. J. Nutr. 2015, 114, 2093–2102. [Google Scholar] [CrossRef] [Green Version]
  92. Mendonca, R.D.; Lopes, A.C.; Pimenta, A.M.; Gea, A.; Martinez-Gonzalez, M.A.; Bes-Rastrollo, M. Ultra-Processed Food Consumption and the Incidence of Hypertension in a Mediterranean Cohort: The Seguimiento Universidad de Navarra Project. Am. J. Hypertens. 2017, 30, 358–366. [Google Scholar] [CrossRef] [Green Version]
  93. Thomson, J.L.; Landry, A.S.; Tussing-Humphreys, L.M.; Goodman, M.H. Diet quality of children in the United States by body mass index and sociodemographic characteristics. Obes. Sci. Pract. 2020, 6, 84–98. [Google Scholar] [CrossRef] [Green Version]
  94. Jakicic, J.M. The Effect of Physical Activity on Body Weight. Obes. J. 2009, 17, S34–S38. [Google Scholar] [CrossRef]
  95. Beccuti, G.; Pannain, S. Sleep and obesity. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14, 402–412. [Google Scholar] [CrossRef] [Green Version]
  96. Rampersaud, E.; Mitchell, B.D.; Pollin, T.I.; Fu, M.; Shen, H.; O’Connell, J.R.; Ducharme, J.L.; Hines, S.; Sack, P.; Naglieri, R.; et al. Physical activity and the association of common FTO gene variants with body mass index and obesity. Arch. Intern. Med. 2008, 168, 1791–1797. [Google Scholar] [CrossRef] [Green Version]
  97. Pouliot, M.C.; Després, J.P.; Lemieux, S.; Moorjani, S.; Bouchard, C.; Tremblay, A.; Nadeau, A.; Lupien, P.J. Waist Circumference and Abdominal Sagittal Diameter: Best Simple Anthropometric Indexes of Abdominal Visceral Adipose Tissue Accumulation and Related Cardiovascular Risk in Men and Women. Am. J. Cardiol. 1994, 73, 460–468. [Google Scholar] [CrossRef]
  98. Akash, M.S.H.; Rehman, K.; Liaqat, A. Tumor Necrosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus. J. Cell. Biochem. 2018, 119, 105–110. [Google Scholar] [CrossRef] [PubMed]
  99. Cicha, I.; Urschel, K. TNF-&alpha in the cardiovascular system: From physiology to therapy. Int. J. Interferon Cytokine Mediat. Res. 2015, 7, 9–25. [Google Scholar] [CrossRef] [Green Version]
  100. Urpi-Sarda, M.; Casas, R.; Chiva-Blanch, G.; Romero-Mamani, E.S.; Valderas-Martinez, P.; Salas-Salvado, J.; Covas, M.I.; Toledo, E.; Andres-Lacueva, C.; Llorach, R.; et al. The Mediterranean diet pattern and its main components are associated with lower plasma concentrations of tumor necrosis factor receptor 60 in patients at high risk for cardiovascular disease. J. Nutr. 2012, 142, 1019–1025. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  101. Qu, D.; Liu, J.; Lau, C.W.; Huang, Y. IL-6 in diabetes and cardiovascular complications. Br. J. Pharmacol. 2014, 171, 3595–3603. [Google Scholar] [CrossRef] [Green Version]
  102. Mozaffarian, D.; Pischon, T.; Hankinson, S.E.; Rifai, N.; Joshipura, K.; Willett, W.C.; Rimm, E.B. Dietary intake of trans fatty acids and systemic inflammation in women. Am. J. Clin. Nutr. 2004, 79, 606–612. [Google Scholar] [CrossRef]
  103. Estruch, R. Anti-inflammatory effects of the Mediterranean diet: The experience of the PREDIMED study. Proc. Nutr. Soc. 2010, 69, 333–340. [Google Scholar] [CrossRef] [Green Version]
  104. Sahin-Efe, A.; Katsikeris, F.; Mantzoros, C.S. Advances in adipokines. Metabolism 2012, 61, 1659–1665. [Google Scholar] [CrossRef]
  105. Katsiki, N.; Mantzoros, C.; Mikhailidis, D.P. Adiponectin, lipids and atherosclerosis. Curr. Opin. Lipidol. 2017, 28, 347–354. [Google Scholar] [CrossRef]
  106. Sparrenberger, K.; Sbaraini, M.; Cureau, F.V.; Telo, G.H.; Bahia, L.; Schaan, B.D. Higher adiponectin concentrations are associated with reduced metabolic syndrome risk independently of weight status in Brazilian adolescents. Diabetol. Metab. Syndr. 2019, 11, 40. [Google Scholar] [CrossRef]
  107. Shafiee, G.; Ahadi, Z.; Qorbani, M.; Kelishadi, R.; Ziauddin, H.; Larijani, B.; Heshmat, R. Association of adiponectin and metabolic syndrome in adolescents: The caspian-III study. J. Diabetes Metab. Disord. 2015, 14, 89. [Google Scholar] [CrossRef] [Green Version]
  108. Izadi, V.; Azadbakht, L. Specific dietary patterns and concentrations of adiponectin. J. Res. Med. Sci. 2015, 20, 178–184. [Google Scholar] [PubMed]
  109. Berger, S.; Polotsky, V.Y. Leptin and Leptin Resistance in the Pathogenesis of Obstructive Sleep Apnea: A Possible Link to Oxidative Stress and Cardiovascular Complications. Oxid. Med. Cell. Longev. 2018, 2018, 5137947. [Google Scholar] [CrossRef]
  110. Kohler, J.A.; Moon, R.J.; Wright, S.; Willows, E.; Davies, J.H. Increased adiposity and altered adipocyte function in female survivors of childhood acute lymphoblastic leukaemia treated without cranial radiation. Horm. Res. Paediatr. 2011, 75, 433–440. [Google Scholar] [CrossRef] [PubMed]
  111. Ganji, V.; Kafai, M.R.; McCarthy, E. Serum leptin concentrations are not related to dietary patterns but are related to sex, age, body mass index, serum triacylglycerol, serum insulin, and plasma glucose in the US population. Nutr. Metab. (Lond.) 2009, 6, 3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  112. Ridker, P.M.; Cook, N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 2004, 109, 1955–1959. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  113. Vandermorris, A.; Sampson, L.; Korenblum, C. Promoting adherence in adolescents and young adults with cancer to optimize outcomes: A developmentally oriented narrative review. Pediatr. Blood Cancer 2020, 67, e28128. [Google Scholar] [CrossRef]
  114. Kleinke, A.M.; Classen, C.F. Adolescents and young adults with cancer: Aspects of adherence—A questionnaire study. Adolesc. Health Med. Ther. 2018, 9, 77–85. [Google Scholar] [CrossRef] [Green Version]
  115. Demark-Wahnefried, W.; Werner, C.; Clipp, E.C.; Guill, A.B.; Bonner, M.; Jones, L.W.; Rosoff, P.M. Survivors of childhood cancer and their guardians. Cancer 2005, 103, 2171–2180. [Google Scholar] [CrossRef]
  116. Banfield, E.C.; Liu, Y.; Davis, J.S.; Chang, S.; Frazier-Wood, A.C. Poor Adherence to US Dietary Guidelines for Children and Adolescents in the National Health and Nutrition Examination Survey Population. J. Acad. Nutr. Diet 2016, 116, 21–27. [Google Scholar] [CrossRef] [Green Version]
  117. Hebert, J.R.; Clemow, L.; Pbert, L.; Ockene, I.S.; Ockene, J.K. Social Desirability Bias in Dietary Self-Report May Compromise the Validity of Dietary Intake Measures. Int. J. Epidemiol. 1995, 24, 389–398. [Google Scholar] [CrossRef]
  118. Hebert, J.R.; Ma, Y.; Clemow, L.; Ockene, I.S.; Saperia, G.; Stanek, E.J.; Merriam, P.A.; Ockene, J.K. Gender Differences in Social Desirability and Social Approval Bias in Dietary Self-Report. Am. J. Epidemiol. 1997, 146, 1046–1055. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Distribution of the dietary scores among participants. (a) MEDAS (Mediterranean Diet Adherence Screener) score; (b) KIDMED (Mediterranean Diet Quality Index for children and adolescents) score; (c) HDI (Healthy Diet Indicator)-2018 score; (d) HEI (Healthy Eating Index)-2015 score; (e) E-DII (Energy-adjusted dietary Inflammatory Index) score; (f) FRAP (Ferric reducing ability of plasma) score; (g) contribution of ultra-processed foods according to the NOVA classification.
Figure 1. Distribution of the dietary scores among participants. (a) MEDAS (Mediterranean Diet Adherence Screener) score; (b) KIDMED (Mediterranean Diet Quality Index for children and adolescents) score; (c) HDI (Healthy Diet Indicator)-2018 score; (d) HEI (Healthy Eating Index)-2015 score; (e) E-DII (Energy-adjusted dietary Inflammatory Index) score; (f) FRAP (Ferric reducing ability of plasma) score; (g) contribution of ultra-processed foods according to the NOVA classification.
Nutrients 12 02137 g001
Figure 2. Inflammatory biomarker levels (y axis) according to nutritional scores (x axis). (a) TNF-α (pg/mL) in non-obese; (b) TNF-α in obese; (c) adiponectin (ng/mL) in non-obese; (d) adiponectin level in obese; * p < 0.05 tertile 3 vs. 1; ϯ p < 0.05 tertile 2 vs. 1. MEDAS, Mediterranean Diet Adherence Screener; KIDMED, Mediterranean Diet Quality Index for children and adolescents; HDI-2018, Healthy Diet Indicator; HEI-2015, Healthy Eating Index; E-DII, Energy-adjusted dietary Inflammatory Index; FRAP, Ferric reducing ability of plasma; Ultra-processed foods.
Figure 2. Inflammatory biomarker levels (y axis) according to nutritional scores (x axis). (a) TNF-α (pg/mL) in non-obese; (b) TNF-α in obese; (c) adiponectin (ng/mL) in non-obese; (d) adiponectin level in obese; * p < 0.05 tertile 3 vs. 1; ϯ p < 0.05 tertile 2 vs. 1. MEDAS, Mediterranean Diet Adherence Screener; KIDMED, Mediterranean Diet Quality Index for children and adolescents; HDI-2018, Healthy Diet Indicator; HEI-2015, Healthy Eating Index; E-DII, Energy-adjusted dietary Inflammatory Index; FRAP, Ferric reducing ability of plasma; Ultra-processed foods.
Nutrients 12 02137 g002
Table 1. Demographic and clinical characteristics of participants.
Table 1. Demographic and clinical characteristics of participants.
Total
N = 241
Adults
N = 156
Children
N = 85
Median (range or interquartile range 1)
Age at visit, years (range)21.3 (8.5–40.9)24.6 (18.0–40.9)16.2 (8.5–17.9)
Age at cancer diagnosis, years (range)4.7 (0.9–18.0)6.5 (0.9–18.0)3.5 (1.3–10.9)
Time since end of treatment, years (range)12.9 (3.3–26.1)16.11 (3.9–26.1)9.6 (3.3–13.4)
Gender (males, %)49.449.449.4
CRT exposure (n, %)142 (58.9%)108 (69.2%)34 (40.0%)
BMI (kg/m2)23.5 (20.9–26.1)24.3 (21.7–27.4)21.8 (19.2–24.1)
WHtR0.50 (0.46–0.55)0.51 (0.48–0.58)0.49 (0.45–0.52)
WC (cm)85.7 (76.0–93.0)89.0 (79.5–97.0)79.9 (72.0–84.0)
Glucose (mmol/L)5.0 (4.8–5.3)5.0 (4.8–5.4)5.0 (4.8–5.3)
Insulin (pmol/L)53.3 (37.6–75.8)50.1 (35.2–68.6)58.1 (42.9–81.1)
HOMA-IR1.7 (1.2–2.5)1.7 (1.1–2.3)1.9 (1.3–2.7)
TC (mmol/L)4.37 (3.87–5.01)4.59 (4.10–5.15)4.18 (3.61–4.63)
TG (mmol/L)0.91 (0.66–1.25)0.97 (0.72–1.38)0.82 (0.62–1.07)
LDL-C (mmol/L)2.57 (2.13–3.16)2.73 (2.22–3.32)2.36 (2.04–2.82)
HDL-C (mmol/L)1.30 (1.12–1.49)1.31 (1.13–1.52)1.29 (1.09–1.45)
SBP (mmHg)115 (108–124)117 (110–125)112 (104–119)
DBP (mmHg)65 (59–70)67 (63–72)62 (57–65)
n = 78n = 38n = 40
Apo A1 (mg/mL)2.32 (1.94–2.65)2.46 (1.98–2.72)2.18 (1.90–2.52)
Apo B100 (g/L)0.82 (0.71–0.94)0.85 (0.72–0.97)0.79 (0.68–0.92)
1 Interquartile range: 25th and 75th percentiles, unless otherwise specified. CRT, cranial radiation therapy; BMI, body mass index; WHtR, waist-to-height ratio; WC, waist circumference; HOMA-IR, homeostasis model assessment-insulin resistance; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure.
Table 2. Descriptive statistics of the dietary scores.
Table 2. Descriptive statistics of the dietary scores.
Score (Range)NMeanMedianSDMinMax
MEDAS (0–14)1564.264.001.871.0010.00
KIDMED (−4–12)853.454.002.36−2.009.00
HDI-2018 (0–9)2414.064.001.560.009.00
HEI-2015 (0–100)24159.7860.0010.5835.0085.00
E-DII (−8.87–7.98)241−0.92−1.061.61−4.80+3.23
FRAP (≥0 mmol/day)24111.899.787.641.9648.79
% UPF (0–100%) 119151.3350.6916.116.9393.36
1 Percentage of caloric intake from ultra-processed foods (Group 4) based on the NOVA classification. MEDAS, Mediterranean Diet Adherence Screener; KIDMED, Mediterranean Diet Quality Index for children and adolescents; HDI-2018, Healthy Diet Indicator; HEI-2015, Healthy Eating Index; E-DII, Energy-adjusted dietary Inflammatory Index; FRAP, Ferric reducing ability of plasma; UPF, Ultra-processed foods; SD, standard deviation; Min, minimum; Max, maximum.
Table 3. Associations between adherence to E-DII score and anthropometric and metabolic parameters.
Table 3. Associations between adherence to E-DII score and anthropometric and metabolic parameters.
E-DII Score
ParametersTertile 1Tertile 2 Tertile 3
−2.67
(−4.80–−1.75) 1
−1.05
(−1.71–−0.35) 1
0.97
(−0.34–3.23) 1
OR (95% CI)OR (95% CI) 2
Tertile
2 vs. 1
pOR (95% CI) 2
Tertile
3 vs. 1
pOR (95% CI) 2
Tertiles
2 and 3 vs. 1
p
High
BMI
-1.297
(0.50–3.34)
0.591.260
(0.47–3.41)
0.651.280
(0.55–3.01)
0.57
High
WC
-1.089
(0.54–2.18)
0.811.574
(0.76–3.26)
0.221.283
(0.69–2.37)
0.43
High
BP
-3.029
(1.01–9.11)
0.0491.135
(0.35–3.71)
0.831.928
(0.68–5.44)
0.21
High
HOMA-IR
-2.667
(1.11–6.43)
0.031.349
(0.50–3.68)
0.562.047
(0.89–4.70)
0.09
Low
HDL-C
-2.318
(1.04–5.16)
0.042.414
(1.04–5.58)
0.042.359
(1.13–4.92)
0.02
High
LDL-C
-1.200
(0.50–2.89)
0.681.183
(0.48–2.93)
0.721.192
(0.54–2.62)
0.66
High
TG
-0.937
(0.34–2.59)
0.901.658
(0.62–4.41)
0.311.240
(0.52–2.94)
0.63
1 Mean score (range); 2 Model adjusted for gender and survival time. Cut-off values are described in Supplementary Table S1. OR, odds ratio; CI, confidence interval; BMI, body mass index; WC, waist circumference; BP, blood pressure; HOMA-IR, homeostasis model assessment-insulin resistance; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; TG, triglycerides.
Table 4. Associations between ultra-processed foods and anthropometric and metabolic parameters.
Table 4. Associations between ultra-processed foods and anthropometric and metabolic parameters.
% Ultra-Processed Foods According to the NOVA Classification
ParametersTertile 1Tertile 2 Tertile 3
34.2%
(6.9–43.0%) 1
50.0%
(43.7–56.5%) 1
69.3%
(56.6–93.4%) 1
OR (95% CI)OR (95% CI) 2
Tertile
2 vs. 1
pOR (95% CI) 2
Tertile
3 vs. 1
pOR (95% CI) 2
Tertiles
2 and 3 vs. 1
p
High
BMI
-0.360
(0.10–1.24)
0.110.929
(0.34–2.58)
0.890.619
(0.25–1.54)
0.30
High
WC
-0.622
(0.28–1.37)
0.240.968
(0.44–2.13)
0.940.772
(0.39–1.51)
0.45
High
BP
-0.781
(0.24–2.57)
0.681.078
(0.36–3.33)
0.890.934
(0.35–2.53)
0.89
High
HOMA-IR
-0.341
(0.11–1.03)
0.060.763
(0.30–1.97)
0.580.533
(0.23–1.23)
0.14
Low
HDL-C
-1.410
(0.55–3.64)
0.483.885
(1.54–9.80)
0.0042.323
(1.02–5.28)
0.04
High
LDL-C
-0.407
(0.15–1.13)
0.090.728
(0.29–1.84)
0.500.556
(0.25–1.26)
0.16
High
TG
-2.998
(0.74–12.1)
0.125.434
(1.38–21.4)
0.024.021
(1.12–14.5)
0.03
1 Mean score (range); 2 Model adjusted for gender, survival time and energy intake. Cut-off values are described in Supplementary Table S1. OR, odds ratio; CI, confidence interval; BMI, body mass index; WC, waist circumference; BP, blood pressure; HOMA-IR, homeostasis model assessment-insulin resistance; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; TG, triglycerides.
Table 5. Association between adherence to nutritional scores and having ≥2 cardiometabolic complications.
Table 5. Association between adherence to nutritional scores and having ≥2 cardiometabolic complications.
Presence of 2 or More Cardiometabolic Complications
ScoresOR (95% CI)
Tertile 1
OR (95% CI)
Tertile
2 vs. 1
pOR (95% CI)
Tertile
3 vs. 1
pOR (95% CI)
Tertiles
2 and 3 vs. 1
p
MEDAS 2-0.800
(0.33–1.97)
0.631.380
(0.54–3.50)
0.301.279
(0.58–2.80)
0.54
KIDMED 2-0.424
(0.12–1.57)
0.20 0.735
(0.23–2.40)
0.610.728
(0.25–2.13)
0.56
HDI-2018 2-1.079
(0.52–2.23)
0.841.191
(0.58–2.43)
0.630.728
(0.25–2.13)
0.56
HEI-2015 3-1.053
(0.52–2.12)
0.880.750
(0.36–1.55)
0.440.911
(0.49–1.68)
0.77
E-DII 3-2.506
(1.22–5.15)
0.011.613
(0.74–3.50)
0.232.076
(1.07–4.07)
0.03
FRAP 2- 1.509
(0.73–3.13)
0.271.245
(0.57–2.73)
0.581.391
(0.71–2.71)
0.33
% UPF 2,4-0.647
(0.29–1.47)
0.301.128
(0.51–2.49)
0.770.856
(0.43–1.70)
0.66
Presence of at least two of these four factors: obesity, pre-hypertension/hypertension, insulin resistance and dyslipidemia; 2 Model adjusted for gender, survival time and energy intake; 3 Model adjusted for gender and survival time; 4 %UPF, percentage of contribution of ultra-processed foods to total dietary energy intake using NOVA classification. OR, odds ratio; CI, confidence interval.

Share and Cite

MDPI and ACS Style

Bérard, S.; Morel, S.; Teasdale, E.; Shivappa, N.; Hebert, J.R.; Laverdière, C.; Sinnett, D.; Levy, E.; Marcil, V. Diet Quality Is Associated with Cardiometabolic Outcomes in Survivors of Childhood Leukemia. Nutrients 2020, 12, 2137. https://0-doi-org.brum.beds.ac.uk/10.3390/nu12072137

AMA Style

Bérard S, Morel S, Teasdale E, Shivappa N, Hebert JR, Laverdière C, Sinnett D, Levy E, Marcil V. Diet Quality Is Associated with Cardiometabolic Outcomes in Survivors of Childhood Leukemia. Nutrients. 2020; 12(7):2137. https://0-doi-org.brum.beds.ac.uk/10.3390/nu12072137

Chicago/Turabian Style

Bérard, Sophie, Sophia Morel, Emma Teasdale, Nitin Shivappa, James R. Hebert, Caroline Laverdière, Daniel Sinnett, Emile Levy, and Valérie Marcil. 2020. "Diet Quality Is Associated with Cardiometabolic Outcomes in Survivors of Childhood Leukemia" Nutrients 12, no. 7: 2137. https://0-doi-org.brum.beds.ac.uk/10.3390/nu12072137

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop